4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001415889-25-004924
PRESIDENT AND CEO gave up 2,004 shares (to pay taxes)
- PRESIDENT AND CEO acquired 6,758 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jiang Wenbin PRESIDENT AND CEO | 2025-02-18 | Option exercise | +6,758 | 5,194,396 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2025-02-18 | Shares withheld for taxes | −2,004 | $5.31 | $10,641 | 5,192,392 | D |
| Derivatives | |||||||
| Jiang Wenbin PRESIDENT AND CEO | 2025-02-18 | Option exercise · Restricted Stock Units | −6,758 | 24,788 | D | ||
Loading xslF345X05/form4-02202025_110246.xml…